Dodgers rotation uncertainty keeps Tarik Skubal trade in play, says insider
The Los Angeles Dodgers are evaluating the health of their rotation, including Shohei Ohtani’s knee discomfort, as the trade deadline approaches. Analyst Ken Rosenthal says the uncertainty makes a potential acquisition of Detroit Tigers pitcher Tarik Skubal a realistic consideration despite the high cost. The Tigers would likely demand a substantial return of prospects, which could deter the Dodgers from pursuing the trade.
- ▪Shohei Ohtani experienced knee discomfort that led to the cancellation of his bullpen session, raising concerns about the Dodgers' rotation health.
- ▪Blake Snell and Tyler Glasnow are also working toward returns, adding to the rotation uncertainty.
- ▪Ken Rosenthal noted that payroll restrictions under the upcoming CBA and the Dodgers' championship window compel them to consider adding a pitcher like Tarik Skubal.
- ▪Detroit would likely require multiple premium prospects and at least one MLB-ready player in exchange for Skubal, making the deal costly.
New York Post files mainly under news. We currently carry 10,001 of its stories.
Opening excerpt (first ~120 words) tap to expand
MLB Dodgers rotation uncertainty keeps Tarik Skubal trade in play, says insider By Ryan Anderson Published July 26, 2026, 8:29 p.m. ET (function() { var overlay = document.getElementById("nyp-player-lcp-overlay"); if (!overlay) { return; } function hideOverlay() { overlay.remove(); } function afterDCL() { requestAnimationFrame(hideOverlay); } if (document.readyState === "loading") { document.addEventListener("DOMContentLoaded", afterDCL, { once: true }); } else { afterDCL(); } })(); See more of our coverage in your search results. Add The California Post on Google The Los Angeles Dodgers may already possess one of baseball’s deepest rosters, but Ken Rosenthal believes their rotation uncertainty makes a pursuit of Tarik Skubal impossible to dismiss.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at New York Post.
Discussion
0 commentsMore from New York Post
